[Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
D000925:Anticoagulants / Q000494:pharmacology*; D001780:Blood Coagulation Tests; D003374:Coumarins / Q000494:pharmacology*; D005164:Factor IX / Q000096:biosynthesis; D005167:Factor VII / Q000096:biosynthesis; D005169:Factor VIII / Q000096:biosynthesis; D005170:Factor X / Q000096:biosynthesis; D006801:Humans; D008660:Metabolism / Q000187:drug effects; D011516:Prothrombin / Q000096:biosynthesis; D013997:Time Factors; D014812:Vitamin K / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D003374:Coumarins; D014812:Vitamin K; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X
Etude biologique d'un nouvel anticoagulant antivitamine K 3-(alpha-acétonylbenzyl) 4-hydroxycoumarine diméthylaminoéthanol. (A propos de 100 observations)